Cargando…

Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis

Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fushimi, Saki, Horikawa, Yohei, Mizutamari, Hiroya, Mimori, Nobuya, Kato, Yuhei, Sato, Sayaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Association of Rural Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369407/
https://www.ncbi.nlm.nih.gov/pubmed/32704333
http://dx.doi.org/10.2185/jrm.2019-021
_version_ 1783560775007207424
author Fushimi, Saki
Horikawa, Yohei
Mizutamari, Hiroya
Mimori, Nobuya
Kato, Yuhei
Sato, Sayaka
author_facet Fushimi, Saki
Horikawa, Yohei
Mizutamari, Hiroya
Mimori, Nobuya
Kato, Yuhei
Sato, Sayaka
author_sort Fushimi, Saki
collection PubMed
description Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome this limitation, we compared procedural outcomes and the prevention of adverse events of proton pump inhibitor injection with an orally administered active potassium-competitive acid blocker alone. Participants and Methods: We enrolled a total of 150 patients treated for superficial gastric neoplasms at a single institution between April 2015 and December 2018. Patients treated for 2 days with proton pump inhibitor injections following 12 days of oral potassium-competitive acid blocker (proton pump inhibitor group=80) were compared with patients treated for 14 days orally with potassium-competitive acid blocker alone (potassium-competitive acid blocker group=70) using propensity score analysis. We evaluated intragastric pH levels prior to endoscopic submucosal dissection, frequency of intraoperative major bleeding, procedure time, en bloc resection rate, curability, ulcer reduction rate 14 days after endoscopic submucosal dissection, and adverse events (including perforation and postoperative bleeding). Results: Propensity score analysis yielded 43 matched pairs. The comparison demonstrated similar values for the outcomes. For all cases, we observed intragastric pH levels >6.4 prior to endoscopic submucosal dissection. Postoperative bleeding rates were 2.3% (1/43) in the proton pump inhibitor group and 0.0% (0/43) in the potassium-competitive acid blocker group (P=0.315). Conclusions: Oral potassium-competitive acid blocker alone was as effective as proton pump inhibitor injection, with a low incidence of adverse events. Based on these results, proton pump inhibitor injection might be omitted during gastric endoscopic submucosal dissection.
format Online
Article
Text
id pubmed-7369407
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Association of Rural Medicine
record_format MEDLINE/PubMed
spelling pubmed-73694072020-07-22 Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis Fushimi, Saki Horikawa, Yohei Mizutamari, Hiroya Mimori, Nobuya Kato, Yuhei Sato, Sayaka J Rural Med Original Article Purpose: Endoscopic submucosal dissection is a promising method for the resection of superficial gastric neoplasms. To date, several institutions have used proton pump inhibitor injections over the perioperative period. However, there is very little evidence regarding their efficacy. To overcome this limitation, we compared procedural outcomes and the prevention of adverse events of proton pump inhibitor injection with an orally administered active potassium-competitive acid blocker alone. Participants and Methods: We enrolled a total of 150 patients treated for superficial gastric neoplasms at a single institution between April 2015 and December 2018. Patients treated for 2 days with proton pump inhibitor injections following 12 days of oral potassium-competitive acid blocker (proton pump inhibitor group=80) were compared with patients treated for 14 days orally with potassium-competitive acid blocker alone (potassium-competitive acid blocker group=70) using propensity score analysis. We evaluated intragastric pH levels prior to endoscopic submucosal dissection, frequency of intraoperative major bleeding, procedure time, en bloc resection rate, curability, ulcer reduction rate 14 days after endoscopic submucosal dissection, and adverse events (including perforation and postoperative bleeding). Results: Propensity score analysis yielded 43 matched pairs. The comparison demonstrated similar values for the outcomes. For all cases, we observed intragastric pH levels >6.4 prior to endoscopic submucosal dissection. Postoperative bleeding rates were 2.3% (1/43) in the proton pump inhibitor group and 0.0% (0/43) in the potassium-competitive acid blocker group (P=0.315). Conclusions: Oral potassium-competitive acid blocker alone was as effective as proton pump inhibitor injection, with a low incidence of adverse events. Based on these results, proton pump inhibitor injection might be omitted during gastric endoscopic submucosal dissection. The Japanese Association of Rural Medicine 2020-07-17 2020-07 /pmc/articles/PMC7369407/ /pubmed/32704333 http://dx.doi.org/10.2185/jrm.2019-021 Text en ©2020 The Japanese Association of Rural Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Fushimi, Saki
Horikawa, Yohei
Mizutamari, Hiroya
Mimori, Nobuya
Kato, Yuhei
Sato, Sayaka
Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title_full Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title_fullStr Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title_full_unstemmed Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title_short Feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
title_sort feasibility of gastric endoscopic submucosal dissection without using proton pump inhibitor injection: a propensity score analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369407/
https://www.ncbi.nlm.nih.gov/pubmed/32704333
http://dx.doi.org/10.2185/jrm.2019-021
work_keys_str_mv AT fushimisaki feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis
AT horikawayohei feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis
AT mizutamarihiroya feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis
AT mimorinobuya feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis
AT katoyuhei feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis
AT satosayaka feasibilityofgastricendoscopicsubmucosaldissectionwithoutusingprotonpumpinhibitorinjectionapropensityscoreanalysis